• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO.

作者信息

Molinaro Alessandro, Zanta Daniela, Moleti Maria Luisa, Giona Fiorina, Conter Valentino, Rizzari Carmelo, Biondi Andrea, Testi Anna Maria

机构信息

Clinica Pediatrica, Università degli Studi di Milano Bicocca, Fondazione Monza e Brianza per il Bambino e la sua Mamma, Ospedale San Gerardo, Monza, Italy.

Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.

出版信息

Mediterr J Hematol Infect Dis. 2022 Mar 1;14(1):e2022027. doi: 10.4084/MJHID.2022.027. eCollection 2022.

DOI:10.4084/MJHID.2022.027
PMID:35444767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8992615/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a93/8992615/1265dbefdf21/mjhid-14-1-e2022027f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a93/8992615/1265dbefdf21/mjhid-14-1-e2022027f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a93/8992615/1265dbefdf21/mjhid-14-1-e2022027f1.jpg

相似文献

1
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO.全反式维甲酸/三氧化二砷治疗小儿急性早幼粒细胞白血病中严重分化综合征的挑战性管理
Mediterr J Hematol Infect Dis. 2022 Mar 1;14(1):e2022027. doi: 10.4084/MJHID.2022.027. eCollection 2022.
2
Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.Src 家族激酶抑制剂 PP2 增强全反式维甲酸和三氧化二砷联合诱导的急性早幼粒细胞白血病细胞系的分化。
Leuk Res. 2014 Aug;38(8):977-82. doi: 10.1016/j.leukres.2014.05.019. Epub 2014 Jun 4.
3
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.三氧化二砷单药或联合全反式维甲酸用于非高危急性早幼粒细胞白血病诱导治疗的比较
Leuk Res. 2018 Mar;66:85-88. doi: 10.1016/j.leukres.2018.01.019. Epub 2018 Feb 3.
4
Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.粒细胞集落刺激因子增强全反式维甲酸和三氧化二砷的分化诱导作用，并增强急性早幼粒细胞白血病细胞系 HT93A 对砷的摄取。
Oncol Rep. 2012 Nov;28(5):1875-82. doi: 10.3892/or.2012.2006. Epub 2012 Aug 31.
5
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.吉非替尼与全反式维甲酸及三氧化二砷联合应用可诱导急性早幼粒细胞白血病耐药细胞发生髓系分化。
Front Oncol. 2021 Sep 28;11:686445. doi: 10.3389/fonc.2021.686445. eCollection 2021.
6
Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line.Src 家族激酶抑制剂 PP2 对全反式维甲酸或三氧化二砷诱导的急性早幼粒细胞白血病细胞系分化的影响不同。
Cancer Res Treat. 2013 Jun;45(2):126-33. doi: 10.4143/crt.2013.45.2.126. Epub 2013 Jun 30.
7
[Therapies for newly diagnosed acute promyelocytic leukemia].[新诊断急性早幼粒细胞白血病的治疗方法]
Rinsho Ketsueki. 2020;61(9):1166-1173. doi: 10.11406/rinketsu.61.1166.
8
All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.全反式维甲酸和三氧化二砷无法解除急性早幼粒细胞白血病细胞中单核细胞分化驱动因子Irf8的抑制状态。
Cell Death Dis. 2017 May 11;8(5):e2782. doi: 10.1038/cddis.2017.197.
9
[Acute promyelocytic leukemia: state-of-the-art management].[急性早幼粒细胞白血病：最新治疗方法]
Rinsho Ketsueki. 2018;59(6):725-734. doi: 10.11406/rinketsu.59.725.
10
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance).儿童肿瘤协作组中接受白血病协作组研究 CALGB 9710（联盟）方案治疗的小儿急性早幼粒细胞白血病患者的预后。
Pediatr Blood Cancer. 2019 Mar;66(3):e27542. doi: 10.1002/pbc.27542. Epub 2018 Nov 4.

引用本文的文献

1
Acute promyelocytic leukemia in children cancer hospital Egypt.埃及儿童癌症医院的急性早幼粒细胞白血病
Discov Oncol. 2024 Jun 11;15(1):223. doi: 10.1007/s12672-024-01037-6.
2
Roles of PADI4 in the expression of cytokines involved in inflammation and adhesion in differentiated NB4 cells treated with ATRA.PADI4在全反式维甲酸处理的分化型NB4细胞中炎症和黏附相关细胞因子表达中的作用
Exp Ther Med. 2023 Jan 31;25(3):118. doi: 10.3892/etm.2023.11817. eCollection 2023 Mar.

本文引用的文献

1
Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France.法国儿童急性早幼粒细胞白血病对三氧化二砷联合全反式维甲酸的耐受性
Br J Haematol. 2020 Jan;188(1):170-173. doi: 10.1111/bjh.16364. Epub 2019 Dec 6.
2
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.三氧化二砷与全反式维甲酸联合治疗儿童急性早幼粒细胞白血病
Br J Haematol. 2019 Apr;185(2):360-363. doi: 10.1111/bjh.15507. Epub 2018 Jul 20.
3
Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL.
急性早幼粒细胞白血病的风险适应性治疗：来自国际儿童急性早幼粒细胞白血病联盟的研究结果。
Blood. 2018 Jul 26;132(4):405-412. doi: 10.1182/blood-2018-03-836528. Epub 2018 May 22.
4
Long-term outcome of acute promyelocytic leukemia treated with all--retinoic acid, arsenic trioxide, and gemtuzumab.全反式维甲酸、三氧化二砷和吉妥单抗治疗急性早幼粒细胞白血病的长期疗效
Blood. 2017 Mar 9;129(10):1275-1283. doi: 10.1182/blood-2016-09-736686. Epub 2016 Dec 21.
5
Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults.急性早幼粒细胞白血病（APL）：儿童与成人的比较
Mediterr J Hematol Infect Dis. 2014 Apr 15;6(1):e2014032. doi: 10.4084/MJHID.2014.032. eCollection 2014.
6
How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.我们如何预防和治疗急性早幼粒细胞白血病患者的分化综合征。
Blood. 2014 May 1;123(18):2777-82. doi: 10.1182/blood-2013-10-512640. Epub 2014 Mar 13.
7
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.全反式维甲酸和三氧化二砷联合治疗急性早幼粒细胞白血病。
N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
8
The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.急性早幼粒细胞白血病患者的分化综合征：Pethema 组的经验和文献复习。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011059. doi: 10.4084/MJHID.2011.059. Epub 2011 Dec 4.
9
Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.早幼粒细胞白血病中的分化综合征：临床表现、发病机制与治疗。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011048. doi: 10.4084/MJHID.2011.048. Epub 2011 Oct 24.
10
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.体重指数（BMI）升高与采用 AIDA 方案治疗的急性早幼粒细胞白血病患者疾病复发和分化综合征风险升高相关。
Blood. 2012 Jan 5;119(1):49-54. doi: 10.1182/blood-2011-07-369595. Epub 2011 Nov 2.